Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Organ-on-a-chip Market

Organ-on-a-chip Market - Industry Insights,
Trends, and Opportunity Analysis, 2018-2026
Organ-on-a-chip is gaining prominence on the backdrop of regulatory measures on animal testing
and growing complexity in therapeutic applications. Various players are trying to capitalize on
lucrative growth opportunities in the organ-on-a-chip devices market. It is a unique cell culture
process, wherein biomimetic microsystem is used as a platform.
These devices are built on silicone, which can be used to grow internal organs. This finds application
in organ transplantation and also therapeutics. Harvard’s Wyss Institute is engaged in lung-on-chip
production, commercialization of which would help in exponential growth of the organ-on-a-chip
market. Moreover, partnerships of biotech and pharmaceutical companies with universities is
expected to scale up the commercialization process in the near future. This billion dollar industry is
expected to create significant market opportunities for players. Some companies such as Mimetas
are currently engaged in development of kidney-on-a-chip. This technology is gaining traction as this
unique technology greatly reduces the amount of testing carried out on animals, while providing
highly accurate results.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/49
Organ-on-a-chip Market - Regional Analysis
North America and Europe are expected to dominate the overall organ-on-a-chip market throughout
the forecast period. The regions are early adopters of newly developed technology. Moreover,
demand is expected to be further propelled by large consumer base in these regions. North America
spends over 16% of its GDP on healthcare. Moreover, various research activities are carried out in
the region, which is home to some of the leading players in the market. Also, organ transplant rate is
high in the region. Growth of the Europe market is expected to be primarily driven by rising demand
for organ-on-chip in Germany, U.K., and France.
Asia Pacific is a lucrative market for companies engaged in organ-on-a-chip industry. However,
commercialization is not expected to take place in early years. As market is still in its early stage, it